Enzolytics, Inc. (ENZC)
Develops antibody treatments for HIV and other infectious diseases.
$0.00+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+0.0%
The outlook
ENZC is trading near its 52-week lows at $0.0006, sitting roughly a third of the way up from its annual bottom. Price action is mixed relative to moving averages, and analyst coverage is thin. The neutral sentiment score reflects neither clear bullish nor bearish conviction in the market.
What’s behind the score
Price trendMixed vs its moving averages
52-week range36% of the way from its 52-week low to high
Market cap
$2.9M
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—